Who Should Consider Zepbound or Mounjaro
Taken together, a CV claim based on SURPASS-CVOT alone is not straightforward
Widely studied for its potential in weight management, glucose regulation, and metabolic optimization, Tirzepatide is ideal for advanced research into obesity and type 2 diabetes models
On tirzepatide, it most commonly manifests as a dull, diffuse soreness in the legs, arms, or trunk
Sources FDA Prescribing Information: Zepbound (tirzepatide) January 2026 label New England Journal of Medicine: Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) AJMC: FDA Approves Monthly KwikPen Option for Tirzepatide Drugs.com: Tirzepatide (Zepbound) dosing and safety Eli Lilly: Mounjaro Prescribing Information Medical disclaimer This article is for educational purposes only and does not constitute medical advice
RK03696), and catalase (cat